Table 2. Marketing of Stimulant Products According to Medical Specialty, per the Open Payment Program Database (January 1, 2014, to December 31, 2018).
Physician Specialty | Payments, No. (%) | Total Payment Amount, $ (%) | Payment, Median (IQR), $ | Unique Physicians, No. (%)a | Total Active Physicians, No. (%)b | Estimated 5-y Prevalence, % |
---|---|---|---|---|---|---|
Pediatrics | 239 217 (40.4) | 5 003 379 (24.9) | 14 (12-18) | 17 427 (31.6) | 90 766 (9.2) | 19.2 |
Psychiatry | 188 076 (31.8) | 11 392 037 (56.7) | 15 (12-19) | 9660 (17.5) | 54 895 (5.5) | 17.6 |
Family medicine | 106 615 (18.0) | 2 138 459 (10.6) | 14 (12-16) | 17 048 (30.9) | 136 604 (13.8) | 12.5 |
Internal medicine | 32 531 (5.5) | 825 003 (4.1) | 14 (12-17) | 7213 (13.1) | 272 060 (27.4) | 2.7 |
Neurology | 20 077 (3.4) | 637 634 (3.2) | 15 (12-19) | 1235 (2.2) | 20 974 (2.1) | 5.9 |
Otherc | 5391 (0.9) | 104 738 (0.5) | 14 (12-17) | 2522 (4.6) | 416 440 (42.0) | 0.6 |
Abbreviation: IQR, interquartile range.
Overall, 55 105 unique physicians received marketing.
Estimated using National Provider Identifier data from 2014 to 2018.6
Includes anesthesiology, dermatology, emergency medicine, general surgery and subspecialties, obstetrics and gynecology, orthopedic surgery, otorhinolaryngology, pain medicine, physical medicine and rehabilitation, and physicians from other specialties.